Enteral Feeding Devices Market Size, Share & Trends Analysis Report By Product (Giving Set, Enteral Feeding Pump, Percutaneous Endoscopic Gastrostomy Device), By Age Group, By Indication, By End Use, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global enteral feeding devices market size was valued at USD 4.1 billion in 2022 and is projected to grow at a CAGR of 4.8% from 2023 to 2030. The growing geriatric population has resulted in an increased incidence of diabetes, severe pancreatitis, and other gastrointestinal diseases, which aids market growth. In addition, the growing prevalence of these diseases in adult and pediatric populations is expected to drive the market. Adoption of the “Feed Early Enteral Diet Adequately for Maximum Effect” (FEED ME) protocol in surgical trauma ICUs in the U.S. enables subsidies on these devices. Technological advancements such as the introduction of tri-funnel replacement G-tubes and J-tubes with reverse balloon designs are also expected to aid in growth during the forecast period.

According to several NCBI studies, individuals aged over 65 years are at a greater risk of developing chronic illnesses such as Parkinson’s and nervous system disorders. According to WHO, the global population aged 60 years and above increased significantly from around 1 billion in 2020 to about 1.4 billion in 2030 and is expected to almost double by 2050 to reach around 2.1 billion. The number of elderly patients with critical illnesses has increased significantly over the past few years. The risk of malnutrition and frailty among the geriatric opulartion with comorbidities, such as stroke, depression, and dementia, is much higher, mainly owing to various age-related changes in body composition and muscle mass. This results in a reduced ability to perform Activities of Daily Living (ADLs), thereby increasing the risk of falls or injuries.

There has been a constant increase in the prevalence of chronic diseases, such as Alzheimer’s disease, Attention Deficit Hyperactivity Disorder (ADHD), osteoporosis, osteoarthritis, central nervous system disorders, and other diseases, which require clinical dietary management. Amino acid-based enteral nutrition is used in the management of sleep disorders, depression, osteoporosis, fibromyalgia, and post-traumatic stress disorder. EN is intended for the dietary management of patients with impaired or limited capacity to digest, ingest, absorb, and metabolize normal diet and patients having special nutrient requirements. Alzheimer’s disease is one of the common neurodegenerative medical conditions that lead to dementia, behavioral changes, decline in functional ability, and economic burden.

The general lack of awareness and understanding regarding enteral nutrition in the medical community is projected to limit its adoption. It requires prescription and supervision by medical professionals. Although these products are gaining acceptance, they remain poorly understood by patients, physicians, and pharmacists. Dieticians are generally aware of these products; however, most doctors and specialists lack awareness regarding the same. This factor prevents doctors from adopting or prescribing enteral nutrition, which may restrain the growth of the market. Furthermore, not all medical experts are convinced that enteral formula would be successful in the treatment of chronic conditions and their symptoms, which may negatively impact the adoption of enteral feeding products along with treatment.

Studies reported that early nutritional plan initiation among critically ill COVID-19 patients was beneficial in reducing septic complications, decreasing mortality, and shortening the hospital stays. Hence, many organizations reported the initiation of enteral nutrition among such patients. For instance, the American Society for Parenteral and Enteral Nutrition (ASPEN) issued guidelines during the pandemic to initiate enteral nutrition within 24 hours to 48 hours in patients who were unable to take or consume food voluntarily. This increased the demand for enteral feeding devices during the pandemic.

Product Insights

Based on product, the enteral feeding pump segment dominated the enteral feeding devices market in 2022 with a 44.8% share as these pumps are designed for safer & more intuitive nutritional care. Enteral feeding is the process of delivering nutrients directly to the stomach through a tube, and the tube is connected to an electric pump. Growing healthcare infrastructure and technological advancements in the medical devices segment are expected to drive market growth. Technological advancements such as the introduction of compact, reliable, and easy-to-use devices, such as Kangaroo ePump developed by Covidien, are expected to boost the demand for enteral feeding pumps during the forecast period.

The low-profile gastrostomy device is anticipated to expand at a significant pace with a CAGR of 6.2%. It is introduced as an alternative to traditional gastrostomy tubes. Passport low-profile gastrostomy devices by Cook Medical and MIC-KEY by Kimberly-Clark are very popular and highly prescribed feeding tubes, which are easy to conceal and ideal for all individuals.

Age Group Insights

The adult age group segment dominated the market with a revenue share of 91.2% in 2022. A published paper in NCBI stated that approximately 70% to 80% of pregnant women suffer nausea and vomiting during pregnancy. In such cases, enteral nutrition is used to prevent adverse conditions, including fetal intrauterine growth restriction, preterm infant birth incidents, and maternal dehydration.

Enteral feeding involves the administration of liquid nutrients through a tube directly into the gastrointestinal tract. In addition, according to WHO, approximately 45% of deaths in children aged 5 years are associated with undernutrition. According to a report published by UNICEF, approximately 3 million young individuals die every year due to malnutrition. Some types of enteral feeding formulas used for infants are nasojejunal, nasoduodenal, and gastrostomy, as well as jejunostomy tubes.

Indication Insights

Indication segment dominated the market with a revenue share of 34.1% in 2022. Enteral feeding can be used in critically ill patients for many other diseases and conditions, such as COPD, cystic fibrosis, and respiratory disorders. For instance, Pulmocare, an Abbott product, is used as an enteral feed for the treatment of these conditions. Conditions such as inflammation, postoperative stress, and infections can also be treated with the help of enteral feeds.

The orphan diseases segment is projected to increase the fastest CAGR over the forthcoming years. According to the Ministry of Health and Family Welfare (MoHFW), Government of India, approximately 300 million individuals globally are living with rare diseases, and around 72% of these diseases are genetic and approximately 70% of these rare genetic diseases begin in childhood. Thus, due to an increase in awareness about enteral nutrition and a rise in the number of diseases categorized as orphan diseases, the market is expected to grow at the fastest rate over the forecast period.

End Use Insights

Based on end use, hospitals segment dominated the market growth with 58.8% of market share in 2022. The growing awareness among healthcare professionals and others regarding hospital-associated malnutrition is one of the significant factors expected to boost the use and demand for enteral feeding devices in hospitals. Moreover, the increasing number of ICU admissions & re-admissions, increasing demand for enteral foods & formulations among critically or severely ill patients, and rising prevalence of several chronic disorders such as diabetes, cancer, & others are some of the major factors that drive the market growth.

The home care segment is projected to increase the fastest CAGR over the forthcoming year. According to The Oley Foundation, it is estimated that more than 344,000 individuals of all ages in the U.S. are taking home enteral nutrition. Moreover, according to the British Artificial Nutrition Survey (BANS), more than 59% require support for home enteral tube feeding in the UK. Therefore, due to increase in the number of alternative care options and rapid technological advancements, the market is anticipated to grow at a significant rate during the forecast period.

Regional Insights

North America had the largest market share of 37.4% as of 2022. Growing number of premature infants in critical care is a major factor driving the regional market growth. For instance, according to CDC, about 1 in 10 babies was born prematurely in the U.S. in 2021. The market is significantly driven by the increase in the geriatric population, which is more susceptible to chronic diseases that result in various disorders such as gastrointestinal disorders, metabolic disorders, and neurological disorders.

On the other hand, Asia Pacific is anticipated to register the fastest growth rate over the forthcoming years. The region has a large patient pool and geriatric population. Lifestyle changes are leading to an increase in the prevalence of various diseases such as cancer, diabetes, gastrointestinal disorders, and autoimmune diseases. This is ultimately expected to increase the demand for enteral feeding devices for the dietary management of chronic diseases. Japan and China have a large elderly population, which is at a high risk of chronic conditions. Nutritional deficiencies are more common in the geriatric population, and it is expected to boost the demand for enteral feeding devices in Asia Pacific. According to World Hunger Education Service, around 70% of all malnourished children live in Asia.

Key Companies & Market Share Insights

The market players are focusing on product development and other initiatives to strengthen their market position. For instance, in February 2022, ALCOR Scientific announced a partnership with Water Street Healthcare Partners, a strategic healthcare investor. Through this partnership, Water Street committed significant funds to the company’s expansion. Some of the prominent key players in the global enteral feeding devices market include:

• Conmed Corporation

• C.R.Bard

• Cook Medical

• Boston Scientific Corporation

• Moog Inc.

• Fresenius Kabi AG

• Danone Medical Nutrition

• Kimberly-Clark

• Abbott Nutrition

• B Braun Melsungen AG

• Avanos Medical, Inc.

• Cardinal Health

• Applied Medical Technology, Inc.

• Vygon India

• Fidmi Medical

• ALCOR Scientific

• Amsino International, Inc.

Enteral Feeding Devices Market Report Scope

Global Enteral Feeding Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, & country levels and provides an analysis of industry trends in each of the segments from 2018 to 2030. For this study, Grand View Research, Inc. has segmented the global enteral feeding devices report based on product, age group, indication, end use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Giving Set

  • Enteral Feeding Pump

  • Percutaneous Endoscopic Gastrostomy Device

  • Low Profile Gastrostomy Device

  • Nasogastric Tube

  • Gastrostomy Tube

• Age Group Outlook (Revenue, USD Million, 2018 - 2030)

  • Adults 

  • Pediatrics

• Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Alzheimer’s

  • Nutrition Deficiency

  • Cancer Care

  • Diabetes

  • Chronic Kidney Diseases

  • Orphan Diseases

  • Dysphagia

  • Pain Management

  • Malabsorption/GI Disorder/Diarrhea

  • Others

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

    • Cardiology

    • Neurology

    • Critical Care (ICU)

    • Oncology

    • Others

  • Home Care

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain `          

    • Italy

    • Russia

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia

    • Thailand

    • Singapore

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait